The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.
The two-dose Oxford/AstraZeneca vaccine has been hailed as a 'vaccine for the world' because it is cheaper and easier to distribute than some rivals. AstraZeneca has a target to produce 3 billion doses this year and aims to produce over 200 million doses per month by April.
Thank you Thank you Thank you
100% of all vaccines have trials for kids.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: